Pharma CFO Anthony Doyle Plans for Uncertainty
Merck, Sanofi in Deals for Cancer Drug Firms
SEC Charges Drug Firm with Reg FD Violations
DOJ Puts C-Suite Execs in Crosshairs
Botox Maker Allergan Sold to AbbVie for $63B
J&J Gets Boost From Strong Cancer Drug Sales
Ex-Salix CFO Fined $1M for Misstating Inventory
Pfizer Beats Estimates on Strength in Key Drugs
Roche Takes Full Control of Genomic Profiler
Shire Accepts Improved $62B Bid From Takeda
Generic Competition Hits Pfizer’s Q2 Sales
J&J Posts $17.7B in Revenue, Misses Estimates
J&J Boosts Drug Roster With $30B Actelion Deal
J&J Sales Increase 1.7% But Miss Estimates
Lonza to Buy Drug Capsule Maker for $5.5B